North Coast Technology Investors

North Coast Technology Investors, established in 1998 and based in Ann Arbor, Michigan, is a venture capital firm specializing in early-stage technology companies across the United States, particularly in the software and communications sectors. The firm is known for its ability to support promising ventures through all stages of their private funding needs. While North Coast often collaborates with other venture capital firms and corporate partners, it frequently acts as the first or sole investor in the companies it chooses to back. This approach allows North Coast to play a significant role in nurturing innovative technology enterprises.

Lindsay Aspegren

General Partner

Hugo Braun

Co-Founder

20 past transactions

Delphinus Medical Technologies

Series D in 2022
Delphinus Medical Technologies, Inc. is a medical imaging company based in Plymouth, Michigan, with an additional office in Sunnyvale, California. Founded in 2009, the company specializes in developing and commercializing innovative breast cancer screening solutions. Its flagship product, SoftVue, employs a unique circular array transducer technology that utilizes ultrasound to provide three-dimensional and tomographic imaging of the entire breast. This system is designed to differentiate between benign and malignant masses, assess breast cancer risks, and monitor treatment, all while ensuring a comfortable experience for patients without the use of radiation. Delphinus serves hospitals and imaging clinics both in the United States and internationally, aiming to improve early detection and diagnosis of breast cancer.

BetterWorks

Series B in 2019
Betterworks is a leading provider of intelligent performance management software aimed at enhancing workforce effectiveness and engagement. Its enterprise-ready SaaS platform equips organizations with essential tools for continuous performance management, including goal alignment, feedback mechanisms, coaching, and employee recognition. By integrating generative AI and data analytics, Betterworks enables companies to make informed, data-driven decisions regarding performance management, skill development, and career progression. The platform facilitates meaningful manager-employee interactions and captures both structured and unstructured data, offering HR professionals comprehensive insights into employee performance. This holistic approach not only supports employee growth and retention but also drives overall business success by fostering a motivated and aligned workforce across various organizational levels.

BlueWillow Biologics

Series A in 2018
BlueWillow Biologics, Inc. is a clinical-stage biopharmaceutical company based in Ann Arbor, Michigan, specializing in the development of intranasal vaccines and anti-infective products utilizing patented nanotechnology. Founded as a spin-off from the University of Michigan in 1999, the company focuses on creating vaccines that provide mucosal immunity against respiratory and sexually transmitted diseases, including pertussis, pandemic influenza, anthrax, HSV2, chlamydia, and HIV. Its innovative NanoStat vaccine technology features an oil-in-water nanoemulsion that effectively incorporates and delivers multiple antigens while enhancing immune responses. In addition to its vaccine portfolio, BlueWillow Biologics offers NanoBio Protect, a nasal antiseptic solution. The company has established partnerships, including a licensing agreement with Merck for its adjuvant technology and a strategic alliance with Public Health England to further its mission in combating infectious diseases.

Impact Analytical

Venture Round in 2017
Impact Analytical is a contract testing laboratory specializing in analytical services for pharmaceuticals, plastics, consumer products, medical devices, packaging, and specialty chemicals. With over three decades of experience in polymer and chemistry analysis, the company offers a wide range of services including method development, stability testing, extractables & leachables, problem-solving, release testing, competitive analysis, failure analysis, raw material testing, surfactant analysis, among others. Impact Analytical is GMP registered, GLP compliant (FDA, EPA), ISO 9001 certified, and DEA licensed, with a strong track record of FDA audits without any findings. The company stands out for its customer-focused approach, ensuring high-quality results are delivered on-time and within budget.

AmpliFund

Series A in 2016
AmpliFund is a developer of cloud-based grant management software designed to facilitate the entire grant lifecycle for grantmakers, grant seekers, and sub-recipients. The company offers a comprehensive solution that captures grant information as data and automates various activities, enhancing standardization, efficiency, transparency, compliance, and accountability in grant management. Founded by professionals with expertise in grant management, AmpliFund focuses on helping government entities at federal, state, local, and tribal levels to streamline processes, centralize data, and improve reporting capabilities. By providing tools and resources tailored to the needs of its clients, AmpliFund aims to maximize the impact of grant resources and support organizations in realizing the full potential of their funding.

Delphinus Medical Technologies

Series C in 2015
Delphinus Medical Technologies, Inc. is a medical imaging company based in Plymouth, Michigan, with an additional office in Sunnyvale, California. Founded in 2009, the company specializes in developing and commercializing innovative breast cancer screening solutions. Its flagship product, SoftVue, employs a unique circular array transducer technology that utilizes ultrasound to provide three-dimensional and tomographic imaging of the entire breast. This system is designed to differentiate between benign and malignant masses, assess breast cancer risks, and monitor treatment, all while ensuring a comfortable experience for patients without the use of radiation. Delphinus serves hospitals and imaging clinics both in the United States and internationally, aiming to improve early detection and diagnosis of breast cancer.

VNN

Venture Round in 2015
VNN, Inc. operates a prominent high school sports marketing and networking platform that serves as a digital hub for athletes, coaches, and fans. The platform enables athletes to upload videos, photos, stories, and scores, while allowing coaches to report game results to various media outlets. VNN is dedicated to enhancing the experience of high school sports by aggregating the fragmented market and providing advertising and promotional services. The company has established a significant presence, serving schools across multiple states, including Alabama, California, and Texas, and has gained a rapidly growing user base, with over 7 million fans engaging with the platform daily. Founded in 2010 and based in Grand Rapids, Michigan, VNN aims to transform the consumer experience in high school sports by leveraging technology and connectivity.

Larky

Series A in 2014
Larky, Inc. is a mobile and web platform that specializes in marketing and audience engagement. The company provides a mobile platform known as Nudge, which facilitates targeted geo-notifications, and Larky Classic, a mobile engagement solution that enhances communication with members. This platform supports local businesses, promotes cross-selling of products and services, boosts customer loyalty, and generates non-interest income for its clients. Larky also features a merchant-funded loyalty program that offers instant savings at local merchants, enhancing branding opportunities for participating organizations. The company serves a diverse range of clients, including financial institutions, health insurance providers, universities, and media companies across the United States and Canada. Founded in 2011 and based in Ann Arbor, Michigan, Larky was previously known as PerkPerk, Inc.

VNN

Series A in 2014
VNN, Inc. operates a prominent high school sports marketing and networking platform that serves as a digital hub for athletes, coaches, and fans. The platform enables athletes to upload videos, photos, stories, and scores, while allowing coaches to report game results to various media outlets. VNN is dedicated to enhancing the experience of high school sports by aggregating the fragmented market and providing advertising and promotional services. The company has established a significant presence, serving schools across multiple states, including Alabama, California, and Texas, and has gained a rapidly growing user base, with over 7 million fans engaging with the platform daily. Founded in 2010 and based in Grand Rapids, Michigan, VNN aims to transform the consumer experience in high school sports by leveraging technology and connectivity.

Delphinus Medical Technologies

Series B in 2013
Delphinus Medical Technologies, Inc. is a medical imaging company based in Plymouth, Michigan, with an additional office in Sunnyvale, California. Founded in 2009, the company specializes in developing and commercializing innovative breast cancer screening solutions. Its flagship product, SoftVue, employs a unique circular array transducer technology that utilizes ultrasound to provide three-dimensional and tomographic imaging of the entire breast. This system is designed to differentiate between benign and malignant masses, assess breast cancer risks, and monitor treatment, all while ensuring a comfortable experience for patients without the use of radiation. Delphinus serves hospitals and imaging clinics both in the United States and internationally, aiming to improve early detection and diagnosis of breast cancer.

Waymark (formerly Stik)

Series A in 2013
We’re on a mission. At Waymark, we believe great video should be accessible to everyone and we’re building the tools to make that a reality. Whether you're a brand, enterprise, media platform, agency, or even a small business, Waymark’s anyone-can-edit video technology makes it easy to scale video and accelerate your business. With Waymark, anyone can make beautiful videos effortlessly. No creativity required. We’re a team of tenacious people who don’t take no for an answer and live at the intersection of design and technology. We launched Waymark in 2017 and have been building it with care ever since.

Larky

Seed Round in 2012
Larky, Inc. is a mobile and web platform that specializes in marketing and audience engagement. The company provides a mobile platform known as Nudge, which facilitates targeted geo-notifications, and Larky Classic, a mobile engagement solution that enhances communication with members. This platform supports local businesses, promotes cross-selling of products and services, boosts customer loyalty, and generates non-interest income for its clients. Larky also features a merchant-funded loyalty program that offers instant savings at local merchants, enhancing branding opportunities for participating organizations. The company serves a diverse range of clients, including financial institutions, health insurance providers, universities, and media companies across the United States and Canada. Founded in 2011 and based in Ann Arbor, Michigan, Larky was previously known as PerkPerk, Inc.

Livio Radio

Series C in 2012
Livio Radio, operating under Myine Electronics, LLC, specializes in designing and manufacturing electronic audio products. Founded in 2008 and based in Ferndale, Michigan, the company offers a range of Bluetooth Internet radio solutions for smartphones, including iPhones and Android devices, as well as car audio players for both personal and business use. In addition to its hardware, Livio Radio provides the Livio Connect API, a middleware framework that facilitates the interaction between hardware and various mobile phone applications. Its products are distributed through a network of retailers, resellers, and online platforms.

CytoPherx

Series C in 2012
CytoPherx (formerly Nephrion) clinical stage medical device company addressing inflammation-based diseases and conditions. The company’s products are custom configurations of a proprietary selective cytopheresis-based inflammation modulating system.

Delphinus Medical Technologies

Series A in 2010
Delphinus Medical Technologies, Inc. is a medical imaging company based in Plymouth, Michigan, with an additional office in Sunnyvale, California. Founded in 2009, the company specializes in developing and commercializing innovative breast cancer screening solutions. Its flagship product, SoftVue, employs a unique circular array transducer technology that utilizes ultrasound to provide three-dimensional and tomographic imaging of the entire breast. This system is designed to differentiate between benign and malignant masses, assess breast cancer risks, and monitor treatment, all while ensuring a comfortable experience for patients without the use of radiation. Delphinus serves hospitals and imaging clinics both in the United States and internationally, aiming to improve early detection and diagnosis of breast cancer.

CytoPherx

Series A in 2007
CytoPherx (formerly Nephrion) clinical stage medical device company addressing inflammation-based diseases and conditions. The company’s products are custom configurations of a proprietary selective cytopheresis-based inflammation modulating system.

RenaMed Biologics

Venture Round in 2006
RenaMed Biologics a biotechnology company, engages in the development and commercialization of therapies for the treatment of diseases associated with compromised kidney function. The company focuses on patients suffering from acute renal failure and additional indications where kidney function is compromised. It develops RBI-01, which utilizes physiologically active human renal epithelial cells and administered ex vivo, to replace and maintain severely compromised, or lost kidney functions due to illness, or trauma. The company was founded in 1995 as Nephros Therapeutics, Inc. and changed its name to RenaMed Biologics, Inc. in 2005. RenaMed Biologics, Inc. is based in Lincoln, Rhode Island.

Arbortext

Venture Round in 2003
Arbortext is a company that specializes in XML-based software solutions designed for content creation, editing, and publishing across multiple channels. Founded in December 1982 and headquartered in Ann Arbor, Michigan, Arbortext offers enterprise software and authoring tools that facilitate the production of extensive information in various languages and electronic formats. The company's solutions are particularly valuable for organizations needing to manage and disseminate significant volumes of content efficiently. Arbortext has been recognized for its contributions to the field, and it operates under the ownership of Parametric Technology.

NTT Global Networks

Series B in 2001
NTT Global Networks provides telecommunications services. They offer a cloud framework to automatically activate and configure virtualized IT cloud services for branch offices.

ONE (Open Networks Engineering)

Series A in 2000
ONE is an industry leader in convergence management technology—offering comprehensive, web-based solutions for network management. With a thorough understanding of industry needs, their solutions offer ONE access point to a world of converging technology. ONE believes that to effectively manage the convergence of the services and technologies defining the networks of today and tomorrow, management systems and management applications must also converge. Their vision is the creation of a convergence management layer in the network where applications that manage services and equipment can work together seamlessly and can evolve and scale as does the network. Their mission is to make convergence management a reality for their clients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.